I agree with you: the excellent prospects on several fronts, the low capitalization, the imminent listing of Ngio, could be an opportunity for those who want to join Gnbt now, but bearing in mind that nothing is taken for granted, especially in the OTC ..... and despite the continuous constant small dilution to which we are subjected (now we are at 117590000 shares ..)
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links